Cambrian Biopharma
A distributed drug discovery company
Cambrian is a distributed drug discovery company, or a “DisCo.” It partners with leading academic institutions and start-up companies, providing capital and expertise to advance a portfolio of drug development programs targeting nine hallmarks of ageing.
Visit website: https://www.cambrianbio.com/
Details last updated 10-Feb-2021
People at Cambrian Biopharma
James Peyer
Stem cell biologist out to build biotech companies focused on age-related diseases, CEO at Cambrian Biopharma
Cambrian Biopharma News
Telos Biotech parent, Cambrian Bio, to develop robust cell therapies for treating age-related diseases
Longevity Technology - 27-Jun-2023
Novel recombinant protein to manufacture biologically fit cells by safely lengthening telomeres
Read more...Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Read more...Korify Capital plans to invest $100m in longevity and mental health space
FierceBiotech - 22-Dec-2021
Aiming to invest in 15-20 biotech firms, including Cambrian Biopharma, to target drivers of ageing
Read more...A proactive step for next generation drug discovery by Cambrian Biopharma
Longevity Technology - 26-Oct-2021
Novel business approach helps people to live longer with good health
Read more...Cambrian Biopharma raised $60 million in stealth mode
Longevity Technology - 09-Feb-2021
New York-based biotech company with unique approaches to treat age-related diseases
Read more...
